Beirne Wealth Consulting Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Beirne Wealth Consulting Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$410K	Buy
2021 Q1	–	Sell
2020 Q4	$275K	Buy
2020 Q3	$285K	Buy
2019 Q3	–	Sell
2019 Q2	$212K	Sell
2019 Q1	$389K	Sell
2018 Q4	$409K	Buy